Biotechnology Stocks
| # | 7 Derniers Jours | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 111 |  VRTX Vertex Pharmaceuticals Incorporated - Common Stock | 548.05 USD | +1.44% | +8.77% | +14.33% | +38.57% | 138.91 B USD | ||
| 197 |  REGN Regeneron Pharmaceuticals, Inc. - Common Stock | 834.04 USD | +0.90% | +4.03% | +25.93% | +41.11% | 85.87 B USD | ||
| 263 |  ARGX argenx SE - American Depositary Shares | 1039.78 USD | +0.16% | +12.13% | +13.64% | +51.67% | 64.35 B USD | ||
| 288 |  MRNA Moderna, Inc. - Common Stock | 145.13 USD | +8.86% | +125.88% | +164.64% | +435.14% | 57.94 B USD | ||
| 352 |  RVMD Revolution Medicines, Inc. - Common Stock | 209.46 USD | -1.08% | +2.67% | +10.88% | +278.09% | 44.89 B USD | ||
| 445 |  ALNY Alnylam Pharmaceuticals, Inc. - Common Stock | 236.22 USD | +3.02% | +4.63% | -13.94% | -47.90% | 31.61 B USD | ||
| 477 |  BNTX BioNTech SE - American Depositary Shares | 116.57 USD | +5.12% | +25.05% | +30.27% | +5.14% | 27.97 B USD | ||
| 484 |  INSM Insmed Incorporated - Common Stock | 125.77 USD | +0.55% | +0.85% | +17.51% | -22.39% | 27.47 B USD | ||
| 488 |  RPRX Royalty Pharma plc - Class A Ordinary Shares | 61.31 USD | +1.21% | +5.05% | +4.22% | +64.55% | 27.38 B USD | ||
| 505 |  ROIV Roivant Sciences Ltd. - Common Shares | 36.30 USD | -1.47% | +0.22% | +3.21% | +98.25% | 26.22 B USD | ||
| 508 |  INCY Incyte Corporation - Common Stock | 127.81 USD | +0.46% | +6.37% | +8.62% | +50.36% | 25.91 B USD | ||
| 575 |  UTHR United Therapeutics Corporation - Common Stock | 513.12 USD | -1.51% | +2.22% | -3.13% | +65.14% | 22.01 B USD | ||
| 676 |  JAZZ Jazz Pharmaceuticals plc - Ordinary Shares | 254.28 USD | +2.24% | +3.83% | -0.20% | +81.63% | 16.51 B USD | ||
| 687 |  BBIO BridgeBio Pharma, Inc. - Common Stock | 81.50 USD | -1.74% | +2.97% | -3.02% | +42.98% | 15.93 B USD | ||
| 696 |  ASND Ascendis Pharma A/S - American Depositary Shares | 253.29 USD | -0.60% | +2.80% | -0.89% | +23.51% | 15.70 B USD | ||
| 773 |  EXEL Exelixis, Inc. - Common Stock | 54.08 USD | +0.73% | +5.52% | -3.10% | +38.52% | 13.40 B USD | ||
| 779 |  CORT Corcept Therapeutics Incorporated - Common Stock | 122.25 USD | +0.99% | +6.30% | +33.46% | +66.62% | 13.22 B USD | ||
| 794 |  BMRN BioMarin Pharmaceutical Inc. - Common Stock | 66.70 USD | -1.45% | -0.45% | +11.37% | +13.28% | 12.91 B USD | ||
| 818 |  ARWR Arrowhead Pharmaceuticals, Inc. - Common Stock | 87.11 USD | -0.41% | +0.78% | +1.30% | +122.79% | 12.30 B USD | ||
| 821 |  HALO Halozyme Therapeutics, Inc. - Common Stock | 108.17 USD | +1.93% | +9.42% | +31.26% | +61.93% | 12.28 B USD |
Nouvelles Biotechnology Stocks
L’action Capricor Therapeutics bondit après l’extension de l’examen FDA
La FDA prolonge l’examen du Deramiocel de Capricor jusqu’au 22 novembre
GRI Bio présentera les données de phase 2a sur la FPI au congrès ERS
Lexicon reçoit 10 millions $ de Novo Nordisk pour son médicament contre l’obésité
Alnylam présentera des données cliniques sur l’ATTR et l’hypertension à l’ESC
FibroBiologics nomme Leigh Steinberg à son conseil d’administration
BioCardia reçoit la confirmation de la FDA sur le cathéter Helix
Gainers Biotechnology Stocks
 LIMN Liminatus Pharma, Inc. - Class A Common Stock | 5.15 | +4581.82% |
 SCNI Scinai Immunotherapeutics Ltd - American Depositary Shares | 3.22 | +1010.34% |
 ELAB PMGC Holdings Inc. - Common Stock | 6.66 | +991.80% |
 HOWL Werewolf Therapeutics, Inc. - Common Stock | 0.87 | +102.33% |
 ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
 LSTA Lisata Therapeutics, Inc. - Common Stock | 1.55 | +38.39% |
 NTRBW Nutriband Inc. - Warrant | 0.5000 | +25.06% |
 ARCT Arcturus Therapeutics Holdings Inc. - Common Stock | 13.45 | +22.38% |
Losers Biotechnology Stocks
 RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0010 | -52.38% |
 OABIW OmniAb, Inc. - Warrant | 0.1700 | -40.27% |
 ASBPW Aspire Biopharma Holdings, Inc. - Warrant | 0.0131 | -17.09% |
 APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
 XCUR Exicure, Inc. - Common Stock | 1.15 | -11.54% |
 SNTI Senti Biosciences, Inc. - Common Stock | 0.39 | -11.36% |
 CURX Curanex Pharmaceuticals Inc - Common Stock | 4.71 | -10.63% |
 HURA TuHURA Biosciences, Inc. - Common Stock | 2.00 | -9.91% |